1. Home
  2. CDXS

as of 12-01-2025 4:00pm EST

$1.65
$0.08
-4.35%
Stocks Industrials Major Chemicals Nasdaq

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Chart Type:
Time Range:
Founded: 2002 Country:
United States
United States
Employees: N/A City: REDWOOD CITY
Market Cap: 141.8M IPO Year: 2010
Target Price: N/A AVG Volume (30 days): 1.4M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.75 EPS Growth: N/A
52 Week Low/High: $1.52 - $6.08 Next Earning Date: 11-06-2025
Revenue: $52,932,000 Revenue Growth: -17.87%
Revenue Growth (this year): 12.88% Revenue Growth (next year): 21.64%

AI-Powered CDXS Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 77.18%
77.18%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Codexis Inc. (CDXS)

CDXS Dec 1, 2025

Avg Cost/Share

$1.67

Shares

253,533

Total Value

$422,766.28

Owned After

179,989

CDXS Nov 28, 2025

Avg Cost/Share

$1.75

Shares

107,490

Total Value

$188,107.50

Owned After

179,989

CDXS Nov 26, 2025

Avg Cost/Share

$1.74

Shares

153,318

Total Value

$266,972.63

Owned After

179,989

Sell
CDXS Nov 21, 2025

Avg Cost/Share

$1.56

Shares

8,952

Total Value

$13,988.40

Owned After

138,951

SEC Form 4

CDXS Nov 12, 2025

Avg Cost/Share

$1.95

Shares

1,082,459

Total Value

$2,101,031.57

Owned After

179,989

SEC Form 4

Form 1 Form 2
CDXS Nov 11, 2025

Avg Cost/Share

$1.80

Shares

548,211

Total Value

$986,450.87

Owned After

179,989

Sell
CDXS Nov 11, 2025

Avg Cost/Share

$1.74

Shares

1,413

Total Value

$2,458.62

Owned After

87,416

SEC Form 4

CDXS Nov 10, 2025

Avg Cost/Share

$1.73

Shares

208,318

Total Value

$361,369.23

Owned After

179,989

CDXS Nov 7, 2025

Avg Cost/Share

$1.70

Shares

306,682

Total Value

$520,378.02

Owned After

179,989

Erbez Georgia

Chief Financial Officer

Sell
CDXS Oct 13, 2025

Avg Cost/Share

$2.51

Shares

6,239

Total Value

$15,628.70

Owned After

70,636

SEC Form 4

Share on Social Networks: